Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Freude: Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. (0.12 sec) 

Peripheral hyperinsulinemia promotes tau phosphorylation in vivo

- diabetesjournals.org
S Freude, L Plum, J Schnitker, U Leeser, M Udelhoven, … - Diabetes, 2005 - Am Diabetes Assoc
Cerebral insulin receptors play an important role in regulation of energy homeostasis and development
of neurodegeneration. Accordingly, type 2 diabetes characterized by insulin resistance is associated
with an increased risk of developing Alzheimer's disease. Formation of neurofibrillary ...
Cited by 26 - Related articles - BL Direct - All 6 versions

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell …


A Jämsä, K Hasslund, RF Cowburn, A Bäckström, … - … and Biophysical Research …, 2004 - Elsevier
The paired helical filaments of highly phosphorylated tau protein are the main components of
neurofibrillary tangles (NFT) in Alzheimer's disease (AD). Protein kinases including glycogen
synthase kinase 3 beta (GSK3β), cyclin-dependent kinase 5 (Cdk5), and c-Jun N-terminal ...
Cited by 31 - Related articles - All 5 versions

Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after …

- diabetesjournals.org
BJ Clodfelder-Miller, AA Zmijewska, GVW Johnson, RS … - Diabetes, 2006 - Am Diabetes Assoc
Deficient signaling by insulin, as occurs in diabetes, is associated with impaired brain
function, and diabetes is associated with an increased prevalence of Alzheimer's disease. One
of the hallmark pathological characteristics of Alzheimer's disease is the presence of ...
Cited by 17 - Related articles - BL Direct - All 6 versions

Insulin signaling, diabetes mellitus and risk of Alzheimer disease


X Zhu, G Perry, MA Smith - Journal of Alzheimer's Disease, 2005 - IOS Press
Although cognitive dysfunction in diabetic patients has long since been documented [34], diabetic
compli- cations of the central nervous system (CNS) were not extensively studied until recently
[50]. Future studies are obviously needed given the increased understanding of ...
Cited by 15 - Related articles - All 2 versions

Increased risk of type 2 diabetes in Alzheimer disease

- diabetesjournals.org
J Janson, T Laedtke, JE Parisi, PO'Brien, RC Petersen, … - Diabetes, 2004 - Am Diabetes Assoc
Alzheimer disease and type 2 diabetes are characterized by increased prevalence with
aging, a genetic predisposition, and comparable pathological features in the islet and brain
(amyloid derived from amyloid ß protein in the brain in Alzheimer disease and islet ...
Cited by 92 - Related articles - BL Direct - All 8 versions

Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's …


MN Haan - Nature Clinical Practice Neurology, 2006 - nature.com
Mary Haan is Professor of Epidemiology at the University of Michigan, School of Public
Health. She received her doctorate in epidemiology in 1986 from the University of California,
School of Public Health in Berkeley. Dr Haan has worked in public health and medicine ...
Cited by 32 - Related articles - BL Direct - All 4 versions

Probing the physicochemical and structural requirements for glycogen synthase …


P Sivaprakasam, A Xie, RJ Doerksen - Bioorganic & medicinal chemistry, 2006 - Elsevier
Glycogen synthase kinase-3α (GSK-3α) was recently found to be an attractive target for the treatment
of Alzheimer's disease due to its dual action in the formation of both amyloid plaques and neurofibrillary
tangles. It is also a viable target for many other diseases, such as type 2 diabetes. ...
Cited by 8 - Related articles - All 5 versions

Insulin-like growth factor-1 and insulin mediate transient site-selective increases in …


M Lesort, GVW Johnson - Neuroscience, 2000 - Elsevier
The modulation of tau phosphorylation and localization in response to insulin-like growth
factor-1 or insulin was examined in primary cultures of rat cortical neurons. Insulin and
insulin-like growth factor-1 treatment resulted in a rapid and transient increase in tau ...
Cited by 50 - Related articles - BL Direct - All 4 versions

Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism …

- physiology.org
D Dardevet, MC Moore, CA DiCostanzo, B … - American Journal of …, 2005 - Am Physiological Soc
Whether glucagon-like peptide (GLP)-1 requires the hepatic portal vein to elicit its insulin
secretion-independent effects on glucose disposal in vivo was assessed in conscious dogs using
tracer and arteriovenous difference techniques. In study 1, six conscious overnight-fasted ...
Cited by 12 - Related articles - BL Direct - All 6 versions

Intranasal insulin to improve memory function in humans


C Benedict, M Hallschmid, B Schultes, J Born, … - …, 2007 - content.karger.com
Background: Compelling evidence indicates that central nervous insulin enhances learning and
memory and in particular benefits hippocampus-dependent (ie, declarative) memory. Intranasal
administration of insulin provides an effective way of delivering the compound to the ...
Cited by 15 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google